Dr. Craig Bunnell Joins Advisory Board of Cancer Diagnostic and Precision Oncology Platform Developer 4D Path
24. August 2021 10:00 ET
|
4D Path
NEWTON, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided pan-cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Craig A....
World-Renowned Cancer Oncologist, Health Consultant and Entrepreneur Dr. Nelson Teich Added to 4D Path’s Distinguished Advisory Board
04. Mai 2021 10:00 ET
|
4D Path
NEWTON, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Nelson Teich, MD,...
4D Path, University of Leeds Extend Contract to Collaboratively Validate New Technology to Help Doctors More Accurately Diagnose Breast Cancer
16. März 2021 10:00 ET
|
4D Path
NEWTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, has extended its existing partnership with the...
Dr. Jennifer Levin Carter Joins Advisory Board of Novel Precision Oncology Platform Creator 4D Path
15. Dezember 2020 10:00 ET
|
4D Path
NEWTON, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Jennifer Levin Carter,...
FDA Grants Breakthrough Designation to 4D Path for Novel Cancer Diagnostic Solution
18. November 2020 10:00 ET
|
4D Path
NEWTON, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, today announced that the U.S. Food & Drug...